Women with breast cancer may overestimate secondary risks

Key points
- Young women with breast cancer often overestimate both their chance of developing cancer in the other breast and how much removal of that breast is likely to protect them, a new U.S. study suggests.
- In a survey of women diagnosed with cancer in one breast between ages 26 and 40 who chose to have a double mastectomy, almost all said a desire to extend their life was a very important part of the decision.
- However, evidence shows removing the cancer-free breast does not improve survival rates, the study's lead author said.
- "For some women it might be the right decision, but you want to make sure they're making the decision based on the correct information," Shoshana M.
Young women with breast cancer often overestimate both their chance of developing cancer in the other breast and how much removal of that breast is likely to protect them, a new U.S. study suggests.
In a survey of women diagnosed with cancer in one breast between ages 26 and 40 who chose to have a double mastectomy, almost all said a desire to extend their life was a very important part of the decision.
However, evidence shows removing the cancer-free breast does not improve survival rates, the study's lead author said.
"For some women it might be the right decision, but you want to make sure they're making the decision based on the correct information," Shoshana M. Rosenberg, from the Susan F. Smith Center for Women's Cancers at the Dana-Farber Cancer Institute in Boston, told Reuters Health.
Among women with early-stage breast cancer who do not have genetic mutations that increase their risk, past research has found the chance of developing cancer in the second breast to be between 2 and 4 percent over five years.
Although mastectomy does reduce the chance of a second cancer in the breast, a much bigger concern is the risk of developing metastatic disease as a result of the original cancer, Rosenberg said.
Removing the second breast does not affect the risk of the original cancer spreading elsewhere in the body, she added, and thus isn't likely to prolong a woman's life.
More and more women with breast cancer are having both breasts removed, Rosenberg noted, and the trend is most pronounced in young women. To see why that might be, she and her colleagues sent surveys to 123 young women who had opted for double mastectomy, an average of two years after their surgery.
Of those women, 94 percent said the desire to extend the length of life was a "very" or "extremely" important factor in their decision to have both breasts removed.
Women without the BRCA1 or BRCA2 genetic mutations believed about 10 percent of women in their situation would develop a second breast cancer over 5 years.
Survey participants "vastly overestimated their risk," according to Rosenberg.
Still, the majority of them answered correctly that most women with early-stage breast cancer will die of something else. And less than one in five believed women with breast cancer who have both breasts removed live longer than those who don't, the study team reported in the Annals of Internal Medicine.
"Obviously, when they're making this decision it's a very anxious time, especially in younger women," Rosenberg said.
About one in eight U.S. women will be diagnosed with breast cancer during her lifetime. According to a recent study, one in 173 will get the disease before age 40.
Rosenberg said many women who have a double mastectomy undergo breast reconstruction, which can involve extensive surgery and long recovery times and carries a risk of complications.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew presurgery combination therapy may improve outcomes for women with triple-negative breast cancer
The I-SPY 2 trial, an innovative, multidrug, phase II breast cancer trial, has yielded positive results with the first drug to complete testing in the trial. Adding the chemotherapy carboplatin and the molecularly…
17 December 2013
NewsBreast cancer risk related to changes in breast density as women age
Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women as they age, according to research being…
3 December 2013
NewsMultivitamins with minerals may protect older women with invasive breast cancer
Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements containing both multivitamins and minerals. The new research,…


